Facebook
Twitter
Telegram
Report an ErrorFibroGen Balance Sheet 2011-2024 | FGEN
Annual Balance Sheet FibroGen
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-99.5 M | -145 M | -160 M | -652 M | -75.2 M | 7.9 M | -576 M | -76.4 M | -56.3 M | -68.2 M | 20.5 M | 54.4 M | - |
Long Term Debt |
104 K | 137 K | 3 K | 25.4 M | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
14.1 M | 10.3 M | 10.9 M | 1.19 M | 983 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 219 M | 263 M | 239 M | 229 M | 207 M | 180 M | 152 M | 120 M | - |
Total Current Liabilities |
218 M | 274 M | 225 M | 163 M | 103 M | 89 M | 77.3 M | 65.1 M | 67.2 M | - | - | - | - |
Total Liabilities |
586 M | 612 M | 545 M | 385 M | 322 M | 352 M | 316 M | 294 M | 274 M | 243 M | 189 M | 143 M | - |
Deferred Revenue |
12.7 M | 12.7 M | 15.9 M | 21.7 M | 490 K | 13.8 M | 7.97 M | 7.99 M | 12.7 M | 9.22 M | 5.74 M | 2.39 M | - |
Retained Earnings |
-1.84 B | -1.56 B | -1.26 B | -974 M | -785 M | -716 M | -596 M | -470 M | -408 M | -322 M | -263 M | -248 M | - |
Total Assets |
424 M | 610 M | 774 M | 827 M | 857 M | 881 M | 899 M | 470 M | 471 M | 484 M | 297 M | 266 M | - |
Cash and Cash Equivalents |
114 M | 156 M | 171 M | 678 M | 126 M | 89.3 M | 674 M | 174 M | 153 M | 165 M | 76.3 M | - | - |
Book Value |
-162 M | -1.48 M | 229 M | 441 M | 535 M | 528 M | 582 M | 175 M | 197 M | 241 M | 108 M | 122 M | - |
Total Shareholders Equity |
-204 M | -21.4 M | 229 M | 441 M | 516 M | 509 M | 563 M | 156 M | 178 M | 241 M | -60.8 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet FibroGen
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
62.5 M | 66.5 M | 70 M | 73.8 M | 76.9 M | 79.6 M | 81.1 M | 83.1 M | 85.9 M | 88.8 M | 5 K | 6 K | 22.2 M | 25.4 M | 25.4 M | 25.4 M | 25.4 M | 37.6 M | 40.7 M | 43.8 M | 46.8 M | - | - | - | - | 97.8 M | 97.8 M | 97.8 M | 97.8 M | 97.4 M | 97.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
552 M | 586 M | 576 M | 575 M | 567 M | 612 M | 563 M | 563 M | 568 M | 545 M | 505 M | 529 M | 397 M | 385 M | 385 M | 385 M | 385 M | 322 M | 280 M | 267 M | 304 M | 352 M | 352 M | 352 M | 352 M | 351 M | 351 M | 351 M | 351 M | 294 M | 294 M | 294 M | 294 M | 274 M | 274 M | 274 M | 274 M | 243 M | 243 M | 243 M | 243 M | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
12.9 M | 12.7 M | 7.32 M | 7.49 M | 16.5 M | 12.7 M | 7.36 M | 6.9 M | 4.74 M | 15.9 M | 23.3 M | 25.2 M | 10.7 M | 6.55 M | 6.55 M | 6.55 M | 6.55 M | 490 K | 257 K | 136 K | 12.1 M | 13.8 M | 13.8 M | 13.8 M | 16.9 M | 16.7 M | 7.97 M | 7.98 M | 7.98 M | 7.99 M | 7.99 M | 7.99 M | 7.99 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 9.22 M | 9.22 M | 9.22 M | 9.22 M | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.87 B | -1.84 B | -1.79 B | -1.72 B | -1.63 B | -1.56 B | -1.49 B | -1.4 B | -1.33 B | -1.26 B | -1.13 B | -1.18 B | -1.05 B | -974 M | -974 M | -974 M | -974 M | -785 M | -687 M | -637 M | -753 M | -716 M | -716 M | -716 M | -716 M | -631 M | -631 M | -631 M | -631 M | -510 M | -470 M | -470 M | -470 M | -452 M | -408 M | -408 M | -408 M | -322 M | -322 M | -322 M | -322 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
366 M | 424 M | 460 M | 515 M | 539 M | 610 M | 609 M | 687 M | 746 M | 774 M | 851 M | 809 M | 787 M | 827 M | 827 M | 827 M | 827 M | 857 M | 894 M | 915 M | 812 M | 881 M | 881 M | 881 M | 881 M | 899 M | 899 M | 899 M | 899 M | 470 M | 470 M | 470 M | 470 M | 471 M | 471 M | 471 M | 471 M | 484 M | 484 M | 484 M | 484 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
106 M | 114 M | 121 M | 153 M | 189 M | 156 M | 156 M | 168 M | 186 M | 171 M | 275 M | 353 M | 434 M | 678 M | 678 M | 678 M | 678 M | 126 M | 197 M | 74.6 M | 81.7 M | 89.3 M | 89.3 M | 89.3 M | 89.3 M | 674 M | 674 M | 674 M | 674 M | 174 M | 174 M | 174 M | 174 M | 153 M | 153 M | 153 M | 153 M | 165 M | 165 M | 165 M | 165 M | 76.3 M | - | - | - | 38.9 M | - | - | - | - | - | - | - |
Book Value |
-186 M | -162 M | -115 M | -60.3 M | -28.9 M | -1.48 M | 46.3 M | 124 M | 178 M | 229 M | 345 M | 280 M | 390 M | 441 M | 441 M | 441 M | 441 M | 535 M | 614 M | 648 M | 508 M | 528 M | 528 M | 528 M | 528 M | 548 M | 548 M | 548 M | 548 M | 175 M | 175 M | 175 M | 175 M | 197 M | 197 M | 197 M | 197 M | 241 M | 241 M | 241 M | 241 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-228 M | -204 M | -157 M | -102 M | -28.9 M | -21.4 M | 46.3 M | 124 M | 178 M | 209 M | 345 M | 280 M | 390 M | 441 M | 422 M | 422 M | 422 M | 516 M | 594 M | 629 M | 489 M | 509 M | 509 M | 509 M | 509 M | 528 M | 528 M | 528 M | 528 M | 156 M | 156 M | 156 M | 156 M | 178 M | 178 M | 178 M | 178 M | 221 M | 221 M | 221 M | 221 M | -60.8 M | - | - | - | -46.3 M | - | - | - | - | - | - | - |
All numbers in USD currency